Posted by Michael Wonder on 24 Sep 2019
The Democrats shepherding Pelosi’s drug pricing bill have taken plenty of campaign cash from pharma
24 September 2019 - The fate of Nancy Pelosi’s sweeping drug pricing bill rests in the hands of lawmakers who received more campaign contributions from the pharmaceutical industry than almost all other Democrats.
Rep. Richard Neal (D-Mass.), who chairs the powerful House Ways and Means Committee, received $111,500 in contributions from pharmaceutical industry political action committees in the 2018 election cycle — fifth-most of any law maker, according to the Center for Responsive Politics. Rep. Frank Pallone (D-N.J.), chairman of the House Energy and Commerce Committee, received $98,500, good for ninth-most.
